Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|August 2, 2003
Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemiaMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|August 22, 2006
Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaineMika H Isohanni, Pertti J Neuvonen, Klaus T Olkkola
Basic & Clinical Pharmacology & Toxicology|January 17, 2004
Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patientsKari Raaska, Virpi Raitasuo, Jouko Laitila, et al.
British Journal of Clinical Pharmacology|October 1, 2008
The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose rangeAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|July 20, 2007
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazoneAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjectsMikko Niemi, Janne T Backman, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|March 3, 2007
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofenAleksi Tornio, Mikko Niemi, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|January 17, 2007
Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamideJari J Lilja, Mikko Niemi, Hanna Fredrikson, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2006
Drug-related visits to a district hospital emergency roomLaura Juntti-Patinen, Tapio Kuitunen, Pertti Pere, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2016
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transportersAleksi Tornio, Pertti J Neuvonen, Mikko Niemi, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|August 2, 2003
Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemiaMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|August 22, 2006
Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaineMika H Isohanni, Pertti J Neuvonen, Klaus T Olkkola
Basic & Clinical Pharmacology & Toxicology|January 17, 2004
Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patientsKari Raaska, Virpi Raitasuo, Jouko Laitila, et al.
British Journal of Clinical Pharmacology|October 1, 2008
The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose rangeAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|July 20, 2007
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazoneAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjectsMikko Niemi, Janne T Backman, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|March 3, 2007
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofenAleksi Tornio, Mikko Niemi, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|January 17, 2007
Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamideJari J Lilja, Mikko Niemi, Hanna Fredrikson, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2006
Drug-related visits to a district hospital emergency roomLaura Juntti-Patinen, Tapio Kuitunen, Pertti Pere, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2016
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transportersAleksi Tornio, Pertti J Neuvonen, Mikko Niemi, et al.
Pageof 20